JournalArta
Monday, November 16, 2026 · JakartaS&P 7,561.67 ▼0.41%USD/IDR 18,254 ▲0.14%
JournalArta
Global Edition
beyond headlines
Advertisement

Biogen (BIIB) Stock Rises 1.17%: Up 2% in Five Sessions

Technical analysis of BIIB stock on November 13, 2026: price 253.40 USD, trend uptrend, RSI 59.2, support 233.48, resistance 254.87.

By Elena Vance
November 16, 20264 min read
Biogen (BIIB) Stock Rises 1.17%: Up 2% in Five Sessions
Logo Biogen — JournalArta illustration

Biogen rose 1.17% to $253.40 on Friday, November 13, extending its gain to 2.03% over five sessions and 8.92% over one month. The move leaves the drugmaker’s shares in an uptrend, above both their 20-day and 50-day moving averages, but close to a 20-day resistance level and with MACD momentum still negative. That mix points to a rising price structure with a near-term test ahead, rather than a fully confirmed acceleration.

Why BIIB is in focus today

    Selected automatically from 8 NASDAQ (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Trend & Price Action

    The 20-day simple moving average (SMA) stood at $249.22, above the 50-day SMA at $233.35, while the share price finished above both. The 20-day average rose 2.18% over five days, reinforcing the upward trend. There was no new moving-average crossover in the latest session; the current structure reflects an established alignment, with the shorter average above the longer one.

    Advertisement

    There is a near-term ceiling.

    At $253.40, Biogen traded at 93% of its 20-day range, between support at $233.48 and resistance at $254.87. It remains below its three-month high of $261.00. A move above $254.87 would put that recent high in focus; failure to hold above the 20-day average at $249.22 would weaken the immediate setup. As shown in the chart, the price is approaching resistance while the moving averages continue to slope upward.

    Price action chart of BIIB
    3-month price action chart of BIIB: price, SMA20/50, Bollinger, support & resistance.

    Oscillators & Momentum

    The RSI at 59.2 is neutral, as is the Stochastic reading of 63.8 for %K and 59.2 for %D. These measures track the pace of recent price changes and suggest neither a clearly overbought market nor a deeply oversold one. They leave room for the trend to continue, but do not by themselves confirm that the latest rise is gathering strength.

    Advertisement

    MACD offers a more cautious signal. Its reading of 5.555 was below the 6.159 signal line, leaving the histogram at -0.604. That negative histogram means short-term momentum remains weaker than the signal line, despite the share price’s advance. The chart shows the momentum indicators alongside the price trend.

    Momentum chart of BIIB
    Momentum chart of BIIB: RSI(14), MACD, Stochastic.

    Volatility & Volume

    The Bollinger Bands, which show how far prices are moving from their recent average, had a middle line at $249.22, an upper band at $260.04 and a lower band at $238.40. The 69% %B reading places the price in the upper portion of the band, while the 8.7% band width is described as normal, with no squeeze or sharp expansion. The shares are approaching the upper band, but the reading alone does not establish a breakout.

    Advertisement

    Trading volume was 1,028,900 shares, or 0.8 times the 20-day average of 1,228,530. That is below normal participation, which tempers the strength of the latest move. On the other hand, OBV, a running measure of whether volume tends to accompany rising or falling prices, was rising. ATR was $8.73, equal to 3.4% of the share price, indicating moderate volatility.

    Fundamental Context

    Technical Verdict: BUY

    JournalArta's research board scores BIIB at +84 on a −100 to +100 scale, past the +60 Buy threshold, driven by price above its 50-day average, 2 bullish vs 0 bearish technical signals, the 20-day average above the 50-day, an uptrend.

    • Entry zone: 246.87 – 253.40
    • Target 1 / 2: 285.90 / 318.41
    • Stop loss: 231.73
    • Reward/risk: 1.5 / 3.0
    • Valid until: 12 Dec 2026
    Advertisement

    The call is void if price falls to 231.73 or fails to revisit the entry zone within five sessions.

    In plain terms: the technical picture for BIIB points up, with a clear exit if it fails at 231.73.

    Technical Verdict: BUY

    BUY is the JournalArta Research verdict, supported by the price above its 50-day average, the 20-day average above the 50-day, and an uptrend with rising OBV. The research score is +84, with two bullish and no bearish technical signals. The main near-term risk is the negative MACD histogram at -0.604 alongside below-average volume; the verdict is invalidated if the price falls below the $231.73 stop-loss level.

    • Ideal entry range: $246.87–$253.40
    • Exit targets: $285.90 (target 1) and $318.41 (target 2)
    • Stop-loss protection: $231.73
    • Reward/risk: 1.5 / 3.0; valid until December 12, 2026
    Advertisement

    In plain English, the technical signals currently favor an upward trend, while weaker momentum and light volume leave the advance open to setbacks.

    Summary Data BIIB

    Last price253.40 USD
    Change 1 day / 5 days / 1 month1.17% / 2.03% / 8.92%
    Trend / MA-crossuptrend / none
    SMA20 / SMA50249.22 / 233.35
    RSI (14) / Stochastic %K59.2 / 63.8
    Bollinger %B / ATR69% / 8.73
    Support / Resistance 20 days233.48 / 254.87
    Data as of14 November 2026 04:00 WIB
    JournalArta research verdict (score)Buy (+84)
    Entry zone246.87 – 253.40
    Target 1 / 2285.90 / 318.41
    Stop loss231.73
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1I’m A Celebrity 2026 Line-Up: Rooney Leads 11 Stars Into Jungle
    2. 2Mavericks Surfers Race to California for Waves Near 50 Feet
    3. 3NYC Medical Examiner Has Not Determined Cause of Death of Beau Rose Jessup
    4. 4Mountaineer Finds Ice Age Cave Bear Graveyard in the Dolomites
    5. 5Rugby League World Cup Final 2026: Kick-Off Times and How to Watch Kangaroos v New Zealand
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Markets · StocksPayPal (PYPL) Stock Latest: Rises 1.68% on Friday, Up 4.6% in a MonthNov 16
    2. Markets · StocksNXP Semiconductors (NXPI) Stock Update: Falls 0.82%, Up 15.6% in a MonthNov 16
    3. World · AustraliaNSW Premier Hits Pause on $110,000 Underquoting FinesNov 16
    4. Business · CompaniesMicrosoft Unlikely to Compensate Businesses for Lost ProductivityNov 16
    5. Advertisement
    6. Markets · StocksAutodesk (ADSK) Stock on Friday: Rises 1.90%, Up 10.2% in a MonthNov 16
    7. Markets · Forex & CommoditiesIndonesia’s November HMA: What Mineral Buyers Should CheckNov 16
    8. Markets · Forex & CommoditiesAussie Dollar Slumps Almost to Its Year Low as AI Jitters SpreadNov 16
    9. Markets · StocksAirbnb (ABNB) Stock on Friday: Climbs 3.12%, Down 1.7% in Five SessionsNov 16